Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: The microbiome plays a critical role in health and disease. While the oral cavity microbiome is well-characterized, the healthy laryngeal microbiome remains underexplored despite its unique immunological role. Laryngeal sampling is more invasive, time-consuming, and costly than salivary and oropharyngeal sampling. Understanding microbial differences between sites can help optimize sampling strategies.
Methods: Nineteen individuals undergoing otolaryngologic surgery for non-oral or laryngeal disease were included. Matched saliva, oropharyngeal swabs, and laryngeal swabs were collected. DNA was extracted, and the V3/V4 region of the 16S rRNA gene was amplified and sequenced using Illumina NextSeq 2000. Amplicon sequence variants were identified via DADA2, and taxa were classified using a hybrid alignment/naïve Bayes approach. Microbial diversity was assessed using alpha and beta diversity measures.
Results: Among 19 participants (31.6% female, mean age 61), most identified as Spanish, Hispanic, or Latino (36.8%). No significant differences were found in taxa diversity between the saliva, oropharynx, and larynx. Core microbiomes shared 13 taxa, with unique taxa in saliva and larynx. While unadjusted comparisons showed that some taxa were differentially abundant between the saliva and the larynx, these differences did not remain significant after correction for multiple comparisons using false discovery rate. Microbiome composition did not predict sample site.
Conclusion: While both salivary and oropharyngeal samples showed similar taxonomic diversity to the larynx, the oropharynx is a superior surrogate, sharing more core taxa, and lacking unique core taxa of its own. The oropharynx could represent a cost-effective alternative for microbiome diagnostics, enhancing patient comfort and clinical feasibility without compromising insights.
Level Of Evidence: Level 3-small prospective cohort study.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/lary.70043 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
GG in a chewable colonizes the nose and facilitates local immune benefits in allergic rhinoconjunctivitis patients.
Microbiol Spectr
September 2025
Laboratory of Applied Microbiology and Biotechnology, Department of Bioscience Engineering, University of Antwerp, Antwerp, Belgium.
Current treatments fall short in managing allergic rhinitis (AR), emphasizing the need for additional strategies. Beneficial bacteria application shows promise in AR; however, most studies focus on oral probiotic administration without monitoring the applied strains in the upper respiratory tract (URT) and their local effects. In this randomized, double-blind, placebo-controlled trial, the probiotic GG was administered via chewable tablets in seasonal AR patients, randomized to probiotic ( = 33) or placebo ( = 31) groups.
View Article and Find Full Text PDFManagement of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalation.
Oral Oncol
August 2025
Department of Otolaryngology - Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, USA; Robert Ebert and Greg Stubblefield Head and Neck Tumor Center at the Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; Department of Genetics, Washin
Background: Management of HPV+ HNSCC with unknown primary (SCCUP) remains controversial. A transoral surgery (TOS) for SCCUP with concurrent neck dissection (ND) has excellent rates of primary lesion detection and removal. This approach allows pathologic staging, directed adjuvant radiation therapy (RT), reduced radiation doses, and decreased rates of chemotherapy.
View Article and Find Full Text PDFThe Role of Neopterin and Interleukin-6 Detection in Saliva and Plasma in Oral and Oropharyngeal Cancer Patients: A Prospective Study.
Clin Exp Dent Res
October 2025
Department of Oral and Maxillofacial surgery, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital, Olomouc, Czech Republic.
Objectives: The incidence of oral and oropharyngeal cancer is continually rising and affects increasingly younger patients. Consequently, many studies focus on early diagnosis using appropriate biomarkers. Neopterin and interleukin-6 (IL-6) are promising predictive and prognostic markers of immune response activation, both systemic and local, due to the anatomical proximity of malignancies to the salivary glands.
View Article and Find Full Text PDFInfluence of oropharyngeal therapy with mother's own milk on the microbiome and metabolome of very preterm infants: a pilot study.
Front Nutr
August 2025
College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Background: Oropharyngeal therapy with mother's own milk (OPT-MOM) may serve as a promising therapeutic approach to elicit immunoprotective and anti-inflammatory benefits for preterm infants.
Objectives: This prospective pilot study aims to investigate whether OPT-MOM alters the oral microbiota, gut microbiota and metabolic profiles in very preterm infants.
Methods: The eligible infants were divided into two groups: the OPT-MOM group and the control group.
Early Insights Into the Healthy Laryngeal Microbiome: A Pilot Study Evaluating Salivary and Oropharyngeal Sampling as Proxies.
Laryngoscope
August 2025
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Objectives: The microbiome plays a critical role in health and disease. While the oral cavity microbiome is well-characterized, the healthy laryngeal microbiome remains underexplored despite its unique immunological role. Laryngeal sampling is more invasive, time-consuming, and costly than salivary and oropharyngeal sampling.
View Article and Find Full Text PDF